ออฟไลน์ด้วยแอป Player FM !
5-Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
Manage episode 393563284 series 3291352
Guest: Dr. Christopher Huerter, Professor and Division Chief Dermatology at Creighton University School of Medicine
Breakthrough treatments: Checkpoint inhibitors like Ipilimumab have changed the way we treat melanoma. Now, a new cutting-edge adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has shown promise in metastatic melanoma treatment trials. A new phase III trial compares TIL to Ipilimumab immunotherapy as first- or second-line treatment in patients with advanced melanoma with remarkable results.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2210233
110 ตอน
5-Minute Check In: Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma
5-Minute Clinical Update and Grand Rounds with Dr. Thomas McGinn
Manage episode 393563284 series 3291352
Guest: Dr. Christopher Huerter, Professor and Division Chief Dermatology at Creighton University School of Medicine
Breakthrough treatments: Checkpoint inhibitors like Ipilimumab have changed the way we treat melanoma. Now, a new cutting-edge adoptive cell therapy with tumor-infiltrating lymphocytes (TIL) has shown promise in metastatic melanoma treatment trials. A new phase III trial compares TIL to Ipilimumab immunotherapy as first- or second-line treatment in patients with advanced melanoma with remarkable results.
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2210233
110 ตอน
ทุกตอน
×ขอต้อนรับสู่ Player FM!
Player FM กำลังหาเว็บ